TopoTarget A/S Confirms Receipt Of Acceptance-To-File Milestone Payment
3/27/2014 9:31:32 AM
Topotarget A/S hereby confirms the receipt of the milestone payment of USD 10 million and 1 million shares from Spectrum Pharmaceuticals, Inc. related to the US Food and Drug Administration’s (FDA) recent acceptance to file BeleodaqTM (belinostat) for peripheral T-cell lymphoma (PTCL).
Help employers find you! Check out all the jobs and post your resume.
comments powered by